MIRA
INFORM REPORT
IDENTIFICATION DETAILS
|
Name : |
ZYDUS WELLNESS LIMITED |
|
|
|
|
Formerly Known
As : |
CARNATION NUTRA ANALOGUE FOODS LIMITED |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2014 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
AHMC00196A |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACC7740G |
|
|
|
|
Legal Form : |
A Public Limited Liability Company. The Company’s Shares are Listed on
the Stock Exchange. |
|
|
|
|
No. of Employees
: |
Information denied by management. |
BUSINESS DETAILS
|
Line of Business : |
Development, Production, Marketing and Distribution of Health and Wellness Products. |
PERFORMANCE REVIEW
For the year ended on 31st March, 2014, the
sales and other income of the Company, on consolidated basis, have increased by
4.6% to Rs. 4225.400 Millions compared to Rs. 4037.800 Millions in the previous
year. Profit before Interest, Exceptional Expenses and Tax was Rs. 1037.600 Millions
compared to Rs. 1079.100 Millions in the previous year. The Profit after Tax
was Rs. 983.100 Millions compared to Rs. 990.300 Millions in the previous year.
EPS of the Company was Rs. 24.69 compared to
Rs. 24.85 in the previous year. The summary of performance of the business of
the Company is provided in the Management Discussion and Analysis Report [MDA]
forming part of this Annual Report.
GENERAL INFORMATION
|
No. of Employees : |
Information denied by management. |
|
|
|
|
Bankers : |
·
Bank of Ashram Road Branch, Ahmedabad, · BNP Paribas Ahmedabad Branch, Ahmedabad, Gujarat, India ·
HDFC Bank Limited Navrangpura Branch, Ahmedabad, Gujarat, India |
|
|
|
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Dhirubhai Shah and Doshi Chartered Accountants |
|
|
|
|
Holding Company : |
·
Cadila Healthcare Limited |
|
|
|
|
Partnership Firm : |
·
Zydus
Wellness - Sikkim |
|
|
|
|
Fellow Subsidiaries / Concern : |
·
Dialforhealth
India Limited ·
Dialforhealth
Unity Limited ·
Dialforhealth
Greencross Limited ·
German
Remedies Limited ·
Zydus
Pharmaceuticals Limited ·
Zydus
Technologies Limited ·
Zydus
Pharmaceuticals (USA) Inc. [USA] ·
Biochem
Pharmaceutical Industries Limited ·
Nesher
Pharmaceuticals (USA) LLC [USA] ·
Zydus
Healthcare (USA) LLC [USA] ·
Zydus
Noveltech Inc. [USA] ·
Hercon
Pharmaceuticals LLC [USA] ·
Zydus
Healthcare S.A. (Pty) Limited [South Africa] ·
Simayla
Pharmaceuticals (Pty) Limited [South Africa] ·
Script
Management Services (Pty) Limited [South Africa] ·
Zydus France, SAS [France] ·
Zydus
Nikkho Farmaceutica Ltda. [Brazil] ·
Zydus
Healthcare, a Partnership Firm ·
Zydus Lanka (Private) Limited [Sri Lanka] ·
Zydus Healthcare Philippines Inc ·
Zydus International Private Limited [Ireland] ·
Zydus Pharma Japan Co. Ltd [Japan] ·
Zydus Netherlands B.V. [the Netherlands] ·
Laboratorios Combix S.L. [Spain] ·
ZAHL B.V. [the Netherlands] ·
Zydus Pharmaceuticals Mexico SA De CV [Mexico] ·
ZAHL Europe B.V. [the Netherlands ·
Zydus Pharmaceuticals Mexico Services Company SA
De C.V.[Mexico] ·
Bremer Pharma GmbH [Germany] ·
Etna Biotech S.R.L. [Italy] |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 30.06.2014
|
Category
of Shareholder |
Total
No. of Shares |
Total
Shareholding as a % of Total No. of Shares |
|
|
|
|
|
(A) Shareholding
of Promoter and Promoter Group |
|
|
|
|
|
|
|
|
179292 |
0.46 |
|
|
28164395 |
72.08 |
|
|
28343687 |
72.54 |
|
|
|
|
|
Total
shareholding of Promoter and Promoter Group (A) |
28343687 |
72.54 |
|
|
|
|
|
(B) Public
Shareholding |
|
|
|
|
|
|
|
|
562887 |
1.44 |
|
|
8087 |
0.02 |
|
|
2023527 |
5.18 |
|
|
3120710 |
7.99 |
|
|
0 |
0.00 |
|
|
5715211 |
14.63 |
|
|
|
|
|
|
1256946 |
3.22 |
|
|
|
|
|
|
2711525 |
6.94 |
|
|
778615 |
1.99 |
|
|
266105 |
0.68 |
|
|
218626 |
0.56 |
|
|
46753 |
0.12 |
|
|
726 |
0.00 |
|
|
5013191 |
12.83 |
|
Total Public
shareholding (B) |
10728402 |
27.46 |
|
|
|
|
|
Total (A)+(B) |
39072089 |
100.00 |
|
|
|
|
|
(C) Shares held
by Custodians and against which Depository Receipts have been issued |
|
|
|
|
0 |
0.00 |
|
|
0 |
0.00 |
|
|
0 |
0.00 |
|
|
|
|
|
Total
(A)+(B)+(C) |
39072089 |
100.00 |
(1)
Indian
Individuals
/ Hindu Undivided Family
Individual
shareholders holding nominal share capital up to Rs. 0.100 MillionFINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
I.
EQUITY
AND LIABILITIES |
|
|
|
|
(1)Shareholders'
Funds |
|
|
|
|
(a) Share Capital |
390.700 |
390.700 |
390.700 |
|
(b) Reserves & Surplus |
2864.900 |
2174.700 |
1477.900 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1)+(2) |
3255.600 |
2565.400 |
1868.600 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities (Net) |
21.800 |
21.900 |
18.500 |
|
(c) Other long term liabilities |
3.700 |
3.700 |
6.000 |
|
(d) long-term provisions |
0.100 |
0.200 |
0.100 |
|
Total Non-current Liabilities (3) |
25.600 |
25.800 |
24.600 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Trade payables |
130.000 |
152.200 |
244.700 |
|
(c) Other current
liabilities |
45.700 |
34.800 |
39.200 |
|
(d) Short-term provisions |
276.100 |
277.700 |
229.500 |
|
Total Current Liabilities (4) |
451.800 |
464.700 |
513.400 |
|
|
|
|
|
|
TOTAL |
3733.000 |
3055.900 |
2406.600 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
302.200 |
285.100 |
298.800 |
|
(ii) Intangible Assets |
229.100 |
228.700 |
228.900 |
|
(iii) Capital
work-in-progress |
0.000 |
0.000 |
0.000 |
|
(iv)
Intangible assets under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
24.500 |
24.500 |
24.500 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
47.400 |
34.400 |
34.900 |
|
(e) Other Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total Non-Current Assets |
603.200 |
572.700 |
587.100 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
1432.000 |
932.800 |
452.600 |
|
(b) Inventories |
46.300 |
67.400 |
60.400 |
|
(c) Trade receivables |
2.300 |
4.600 |
3.600 |
|
(d) Cash and cash
equivalents |
1639.300 |
1461.500 |
1271.700 |
|
(e) Short-term loans and
advances |
8.400 |
15.600 |
28.500 |
|
(f) Other current assets |
1.500 |
1.300 |
2.700 |
|
Total Current Assets |
3129.800 |
2483.200 |
1819.500 |
|
|
|
|
|
|
TOTAL |
3733.000 |
3055.900 |
2406.600 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
|
SALES |
|
|
|
|
|
|
|
Net Revenue from Operations |
2032.500 |
2130.100 |
2535.900 |
|
|
|
Other Income |
116.900 |
138.900 |
88.100 |
|
|
|
TOTAL |
2149.400 |
2269.000 |
2624.000 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Materials Consumed |
517.700 |
572.900 |
574.900 |
|
|
|
Purchases of Stock in Trade |
46.100 |
72.700 |
236.600 |
|
|
|
Changes in Inventories of Finished Goods, Works in Progress and Stock
in Trade |
24.500 |
(0.700) |
116.500 |
|
|
|
Employee Benefits Expenses |
129.500 |
119.600 |
100.700 |
|
|
|
Other Expenses |
501.300 |
488.000 |
786.200 |
|
|
|
TOTAL |
1219.100 |
1252.500 |
1814.900 |
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION |
930.300 |
1016.500 |
809.100 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
24.300 |
23.700 |
23.000 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
906.000 |
992.800 |
786.100 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
(58.500) |
21.700 |
109.300 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX |
964.500 |
971.100 |
676.800 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS YEARS’ BALANCE BROUGHT FORWARD |
1824.700 |
1227.900 |
868.200 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
Transfer to General Reserve |
100.000 |
100.000 |
90.000 |
|
|
|
Interim Dividend |
0.000 |
234.400 |
0.000 |
|
|
|
Proposed Dividend |
234.400 |
0.000 |
195.400 |
|
|
|
Tax on Dividend |
39.900 |
39.900 |
31.700 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
2414.900 |
1824.700
|
1227.900 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
0.300 |
0.200 |
0.000 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Stores & Spares |
1.800 |
1.900 |
0.000 |
|
|
|
Capital Goods |
3.300 |
0.000 |
4.200 |
|
|
|
Others (Repairs to Machinery) |
0.000 |
0.000 |
0.100 |
|
|
TOTAL IMPORTS |
5.100 |
1.900 |
4.300 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
24.69 |
24.85 |
17.32 |
|
RATING & COMMENTS
|
MIRA’s Rating : |
A (65) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
RBI DEFAILTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
LOCATIONS
|
Registered Office: |
House No. 6 and 7, Sigma Commerce Zone, Near Iscon Temple, Sarkhej –
Gandhinagar Highway, Ahmedabad – 380015, Gujarat, India |
|
Tel. No.: |
91-79-26868100 (20 Lines) / 67775888, |
|
Fax No.: |
91-79-26862253 / 67775811 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory : |
7A, 7B and 8, Saket Industrial Estate, Sarkhej Bavla Road, Village
Moraiya, Taluka Sanand, District Ahmedabad, Gujarat, India |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.